idiopathic pulmonary fibrosis

Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Tue, 02/5/19 - 11:19 pm
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics
Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
CP Wire
Fri, 10/26/18 - 09:50 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis
Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
Fri, 10/26/18 - 09:49 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis
Chasing Biogen, the Pliant crew banks a $62M round to fuel their shot at fibrosis targets
Endpoints
Mon, 07/16/18 - 09:57 am
Pliant Therapeutics
IPF
idiopathic pulmonary fibrosis
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
CP Wire
Tue, 05/22/18 - 11:11 am
FibroGen
pamrevlumab
IPF
idiopathic pulmonary fibrosis
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
Mon, 05/21/18 - 10:44 pm
FibroGen
pamrevlumab
idiopathic pulmonary fibrosis
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
CP Wire
Thu, 04/12/18 - 09:23 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
Thu, 04/12/18 - 08:27 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Good news from Galapagos’ pulmonary fibrosis product
GoInPharma
Wed, 08/16/17 - 09:42 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Drugs to Halt, or Reverse, Deadly Lung Scarring? Third Rock Bets $45M it Can Be Done
Forbes
Thu, 02/18/16 - 09:48 am
Third Rock
idiopathic pulmonary fibrosis
Pliant Therapeutics
Bristol-Myers buys rights to fibrosis drug with option to buy developer Promedior
Yahoo/AP
Mon, 08/31/15 - 09:53 am
Bristol-Myers Squibb
PRM-151
idiopathic pulmonary fibrosis
Promedior
EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis
First Word Pharma
Mon, 01/19/15 - 12:02 pm
Boehringer Ingelheim
Ofev
IPF
idiopathic pulmonary fibrosis
Europe
Bristol-Myers beefs up fibrosis pipeline with $444M option deal
Fierce Biotech
Mon, 11/3/14 - 09:28 am
Bristol-Myers Squibb
Galecto Biotech
Denmark
M&A
IPF
idiopathic pulmonary fibrosis
InterMune Gains After Lung Disease Drug Slows Damage
Bloomberg
Mon, 05/19/14 - 09:36 am
InterMune
pirfenidone
IPF
idiopathic pulmonary fibrosis
Biotech Stock Mailbag: Previewing InterMune's Big Week Ahead
TheStreet.com
Fri, 05/16/14 - 10:07 am
InterMune
IPF
idiopathic pulmonary fibrosis
Boehringer Ingelheim
pirfenidone
nintedanib
Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
Motley Fool
Mon, 03/17/14 - 05:05 pm
Chelsea Therapeutics
Northera
Esbriet
idiopathic pulmonary fibrosis
InterMune
InterMune Hits Home Run With Pivotal Lung Drug Study Results
TheStreet.com
Tue, 02/25/14 - 08:14 am
InterMune
pirfenidone
IPF
idiopathic pulmonary fibrosis
InterMune: Esbriet And Ascend Will Drive Growth
Seeking Alpha
Sat, 12/21/13 - 11:32 am
InterMune
Esbriet
idiopathic pulmonary fibrosis
Former Biotech CEO Asks Supreme Court To Review Free Speech Rights
Pharmalot
Thu, 08/8/13 - 02:40 pm
InterMune
idiopathic pulmonary fibrosis
free speech
Actimmune
InterMune Successfully Entering Huge Niche Market Unchallenged
Seeking Alpha
Sun, 07/28/13 - 11:18 am
InterMune
Esbriet
idiopathic pulmonary fibrosis

Pages